Inherited aplastic anaemia

Hematology Journal

Volumn 4, Issue 1, 2003, Pages 3-9

  Dokal, Inderjeet ^a  

^a UNIVERSITY COLLEGE LONDON   (United Kingdom)

Author keywords

Aplastic anaemia; Inherited disorder; Somatic abnormalities

Indexed keywords

ANDROGEN; BUSULFAN; CORTICOSTEROID; CYCLOPHOSPHAMIDE; ERYTHROPOIETIN; FLUDARABINE; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; OXYMETHOLONE; PREDNISOLONE; STEROID; TELOMERASE; CELL CYCLE PROTEIN; DKC1 PROTEIN, HUMAN; HEMOPOIETIC GROWTH FACTOR; NUCLEAR PROTEIN;

APLASTIC ANEMIA; BONE MARROW DEPRESSION; CLINICAL FEATURE; DIAGNOSTIC ACCURACY; DISEASE ASSOCIATION; DYSKERATOSIS CONGENITA; ENZYME ACTIVITY; ENZYME DEFECT; FANCONI ANEMIA; GENE THERAPY; GENETIC DISORDER; HEMATOPOIESIS; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMAN; IDIOPATHIC DISEASE; INHERITANCE; PATHOPHYSIOLOGY; REVIEW; TREATMENT OUTCOME; TREATMENT PLANNING; ADOLESCENT; ADULT; BLOOD; BONE MARROW; CHILD; GENE EXPRESSION REGULATION; GENETIC HETEROGENEITY; GENETICS; HUMAN CHROMOSOME; IMMUNOSUPPRESSIVE TREATMENT; PATHOLOGY; PHYSIOLOGY; PRESCHOOL CHILD; ULTRASTRUCTURE; X CHROMOSOME;

ADOLESCENT; ADULT; ANEMIA, APLASTIC; BONE MARROW; CELL CYCLE PROTEINS; CHILD; CHILD, PRESCHOOL; CHROMOSOMES, HUMAN; CHROMOSOMES, HUMAN, X; DOSAGE COMPENSATION, GENETIC; DYSKERATOSIS CONGENITA; FANCONI ANEMIA; GENETIC HETEROGENEITY; HEMATOPOIETIC CELL GROWTH FACTORS; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMANS; NUCLEAR PROTEINS; OXYMETHOLONE; PREDNISOLONE; TRANSPLANTATION CONDITIONING;

EID: 0037591410     PISSN: 14664860     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.thj.6200215     Document Type: Review

References (36)

1. Alter BP, Young NS. The bone marrow failure syndromes. In: Nathan DG, Orkin HS (eds). Hematology of Infancy and Childhood. WB Saunders: Philadelphia, 1998, pp 237-335.
2. Auerbach AD, Buchwald M, Joenje H. In: Scriver CR et al. (eds). The Metabolic and Molecular Basis of Inherited Disease. McGraw-Hill: New York; 2001, pp 753-768.
3. Joenje H, Patel KJ. The emerging genetic and molecular basis of Fanconi anaemia. Nat Rev Genet 2001; 2: 446-457.
4. Garcia-Higuera I, Kuang Y, Naf D, Wasik J, D'Andrea AD. Fanconi anaemia proteins FANCA, FANCC, and FANCG/XRCC9 interact in a functional nuclear complex. Mol Cell Biol 1999; 19: 4866-4873.
5. Pace P, Johnson M, Tan WM, Mosedale G, Sng C, Hoatlin M et al. FANCE: the link between Fanconi anaemia complex assembly and activity. EMBO J 2002; 21: 3414-3423.
6. Garcia-Higuera I, Taniguchi T, Ganesan S, Meyn MS, Timmers C, Hejna J et al. Interaction of the Fanconi anaemia proteins and BRCA1 in a common pathway. Mol Cell 2001; 7: 249-262.
7. Wang Y, Cortez D, Yazdi P, Neff N, Elledge SJ, Qin J. BASC, a super complex of BRCA1-associated proteins involved in the recognition and repair of aberrant DNA structures. Genes Dev 2000; 14: 927-939.
8. Taniguchi T, Garcia-Higuera I, Xu B, Andreassen PR, Gregory RC, Kim ST et al. Convergence of the Fanconi anaemia and ataxia telangiectasia signalling pathways. Cell 2002; 109: 459-472.
9. Howlett NG, Taniguchi T, Olson S, Cox B, Waisfisz Q, de Die-Smulders C et al. Biallelic inactivation of BRCA2 in Fanconi anaemia. Science 2002; 297: 606-609.
10. Kerr P, Ashworth A. New complexities for BRCA1 and BRCA2. Curr Biol 2001; 11: R668-R676.
11. Guardiola P, Socie G, Pasquini R, Dokal I, Ortega JJ, van Weel-Sipman M et al. Allogeneic stem cell transplantation for Fanconi anaemia. Bone Marrow Transplant 1998; 21(Suppl 2): 24-27.
12. Guardiola Ph, Pasquini R, Dokal I, Ortega JJ, van Weel-Sipman, Marsh JC et al. Outcome of 69 allogeneic stem transplantations for Fanconi anaemia using HLA-matched unrelated donors: a study on behalf of the European Group for Blood and Marrow Transplantation. Blood 2000; 95: 422-429.
13. Kapelushnik J, Or R, Slavin S, Nagler A. A fludarabinebased protocol for bone marrow transplantation in Fanconi's anaemia. Bone Marrow Transplant 1997; 20: 1109 1110.
14. Boulad F, Gillio A, Small TN, George D, Prasad V, Torok-Castanza J et al. Stem cell transplantation for the treatment of Fanconi anaemia using a fludarabine-based cytoreductive regimen and T-cell-depleted related HLA-mismatched peripheral blood stem cell grafts. Br J Haematol 2000; 111: 1153-1157.
15. de Medeiros CR, Silva LM, Pasquini R. Unrelated cord blood transplantation in a Fanconi anaemia patient using fludarabine-based conditioning. Bone Marrow Transplant 2001; 28: 110-112.
16. McCloy M, Almeida A, Daly P, Vulliamy T, Roberts IA, Dokal I. Fludarabine-based stem cell transplantation protocol for Fanconi's anaemia in myelodysplastic transformation. Br J Haematol 2001; 112: 427-427.
17. Liu JM, Kim S, Read EJ, Futaki M, Dokal I, Carter CS et al. Engraftment of hematopoietic progenitor cells transduced with the Fanconi anaemia group C gene (FANCC). Hum Gene Ther 1999; 10: 2337-2346.
18. Dokal I, Chase A, Morgan NV, Coulthard S, Hall G, Mathew CG et al. Positive diepoxybutane test in only one of two brothers found to be compound heterozygotes for Fanconi's anaemia complementation group c mutations. Br J Haematol 1996; 93: 813-816.
19. Waisfisz Q, Morgan NV, Savino M, de Winter JP, van Berkel CG, Hoatlin ME et al. Spontaneous functional correction of homozygous Fanconi anaemia alleles reveals novel mechanistic basis for reverse mosaicism. Nat Genet 1999; 22: 379-383.
20. Dokal I. Dyskeratosis congenita in all its forms. Br J Haematol 2000; 110: 768-779.
21. Devriendt K, Matthijs G, Legius E, Schollen E, Blockmans D, van Geet C et al. Skewed X-chromosome inactivation in female carriers of dyskeratosis congenita. Am J Hum Genet 1997; 60: 581-587.
22. Vulliamy TJ, Knight SW, Dokal I, Mason PJ. Skewed X-inactivation in carriers of X-linked dyskeratosis congenita. Blood 1997; 90: 2213-2216.
23. Connor JM, Gatherer D, Gray FC, Pirrit LA, Affara NA. Assignment of the gene for dyskeratosis congenita to Xq28. Hum Genet 1986; 72: 348-351.
24. Heiss NS, Knight SW, Vulliamy TJ, Klauck SM, Wiemann S, Mason PJ et al. X-linked dyskeratosis congenita is caused by mutations in a highly conserved gene with putative nucleolar functions. Nat Genet 1998; 19: 32-38.
25. Knight SW, Heiss NS, Vulliamy TJ, Aalfs CM, McMahon C, Richmond P et al. Unexplained aplastic anaemia, immunodeficiency, and cerebellar hypoplasia (Hoyeraal-Hreidarsson syndrome) due to mutations in the dyskeratosis congenita gene, DKC1. Br J Haematol 1999; 107: 335-339.
26. Mitchell JR, Wood E, Collins K. A telomerase component is defective in the human disease dyskeratosis congenita. Nature 1999; 402: 551-555.
27. Collins K, Mitchell JR. Telomerase in the human organism. Oncogene 2002; 21: 564-579.
28. Vulliamy T, Marrone A, Goldman F, Dearlove A, Bessler M, Mson PJ et al. The RNA component of telomerase is mutated in autosomal dominant dyskeratosis congenita. Nature 2001; 413: 432-435.
29. Marciniak R, Guarente L. Testing telomerase. Nature 2001; 413: 370-373.
30. Vulliamy T, Marrone A, Dokal I, Mason PJ. Association between aplastic anaemia and mutations in telomerase RNA. Lancet 2002; 359: 2168-2170.
31. Cossu F, Vulliamy TJ, Marrone A, Badiali M, Cao A, Dokal I. A novel DKC1 mutation, severe combined immunodeficiency (T + B-NK- SCID) and bone marrow transplantation in an infant with Hoyeraal-Hreidarsson syndrome. Br J Haematol 2002; 119: 765-768.
32. Draptchinskaia N, Gustavsson P, Andersson B, Pettersson M, Willig TN, Dianzani I et al. The gene encoding ribosomal protein S19 is mutated in Diamond-Blackfan anaemia. Nat Genet 1999; 21: 169-175.
33. Willig T-N, Dratchinskaia N, Dianzani I, Ball S, Niemeyer C, Ramenghi U et al. Mutations in ribosomal protein S19 and Diamond Blackfan anaemia: wide variations in phenotypic expression. Blood 1999; 94: 4294 4306.
34. Dale DC, Person RE, Bolyard A, Aprikyan AG, Bos C, Bonilla MA et al. Mutations in the gene encoding neutrophil elastase in congenital and cyclic neutropenia. Blood 2000; 96: 2317-2322.
35. Ihara K, Ishii E, Eguchi M, Takada H, Suminoe A, Ggood RA et al. Identification of mutations in the c-mpl gene in congenital amegakaryocytic thrombocytopenia. Proc Natl Acad Sci USA 1999; 96: 3132-3136.
36. Dror Y, Freedman MH. Shwachman-Diamond syndrome. Br J Haematol 2002; 118: 701-713.